Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement

Dyslipidemia in patients with diabetes is an important treatment target as a modifiable risk factor for cardiovascular disease (CVD). Although the primary treatment goal for dyslipidemia is to control low-density lipoprotein cholesterol (LDL-C), achieving this goal remains suboptimal according to re...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Diabetes Association 2023-01-01
coleção:	Diabetes & Metabolism Journal
Assuntos:	cholesterol, ldl diabetes mellitus, type 2 dyslipidemias guideline hydroxymethylglutaryl-coa reductase inhibitors
Acesso em linha:	http://www.e-dmj.org/upload/pdf/dmj-2022-0448.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!